Literature DB >> 21182899

Roles of inflammation response in microglia cell through Toll-like receptors 2/interleukin-23/interleukin-17 pathway in cerebral ischemia/reperfusion injury.

M Lv1, Y Liu, J Zhang, L Sun, Z Liu, S Zhang, B Wang, D Su, Z Su.   

Abstract

Microglial activation is one of the causative factors of neuroinflammation in cerebral ischemia. Activation via Toll-like receptors (TLRs) causes increased proinflammatory cytokine expression, such as interleukin-23 (IL-23) and interleukin-17 (IL-17), leading to inflammatory immune responses and neuronal damage. In this study, using a rat focal cerebral ischemia reperfusion (IR) model and an in vitro oxygen-glucose deprivation reperfusion (OGDR) system, we found that TLR2, IL-23 and IL-17 form an axis that leads to increased neuronal apoptosis. TLR2 activation results in IL-23 production which stimulates IL-17 production by microglia. This microglial axis may be a potential therapeutic target to control neuroinflammation in brain IR.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182899     DOI: 10.1016/j.neuroscience.2010.11.066

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  36 in total

Review 1.  Regulation of microglial activation in stroke.

Authors:  Shou-Cai Zhao; Ling-Song Ma; Zhao-Hu Chu; Heng Xu; Wen-Qian Wu; Fudong Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

2.  Association between interleukin-17 gene polymorphisms and risk of coronary artery disease.

Authors:  Lian Shuang; Zhiliang Li; Fengying Chen; Xiaoying Cui; Yuzhen Ning; Youle Su; Mei Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 3.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 4.  Inflammation and adaptive immunity in Parkinson's disease.

Authors:  R Lee Mosley; Jessica A Hutter-Saunders; David K Stone; Howard E Gendelman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

5.  The Use of Hypothermia Therapy in Traumatic Ischemic / Reperfusional Brain Injury: Review of the Literatures.

Authors:  Shoji Yokobori; Janek Frantzen; Ross Bullock; Shyam Gajavelli; Stephen Burks; Helen Bramlett; W Dalton Dietrich
Journal:  Ther Hypothermia Temp Manag       Date:  2011-12-20       Impact factor: 1.286

6.  CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.

Authors:  Louisa Nitsch; Julian Zimmermann; Marius Krauthausen; Markus J Hofer; Raman Saggu; Gabor C Petzold; Michael T Heneka; Daniel R Getts; Albert Becker; Iain L Campbell; Marcus Müller
Journal:  Mol Neurobiol       Date:  2019-06-02       Impact factor: 5.590

7.  Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury.

Authors:  Molly Braun; Kumar Vaibhav; Nancy Saad; Sumbul Fatima; Darrell W Brann; John R Vender; Lei P Wang; Md Nasrul Hoda; Babak Baban; Krishnan M Dhandapani
Journal:  J Immunol       Date:  2017-03-24       Impact factor: 5.422

8.  Involvement of IL-17 in Secondary Brain Injury After a Traumatic Brain Injury in Rats.

Authors:  Tan Li; Yong-Mei Zhang; Dong Han; Rong Hua; Bing-Nan Guo; Shu-Qun Hu; Xian-Liang Yan; Tie Xu
Journal:  Neuromolecular Med       Date:  2017-09-15       Impact factor: 3.843

Review 9.  Preconditioning for traumatic brain injury.

Authors:  Shoji Yokobori; Anna T Mazzeo; Khadil Hosein; Shyam Gajavelli; W Dalton Dietrich; M Ross Bullock
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

10.  Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways.

Authors:  Jian-Ming Zhou; Sha-Sha Gu; Wang Hong Mei; Jun Zhou; Zhen Zhong Wang; Wei Xiao
Journal:  Cell Stress Chaperones       Date:  2016-08-25       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.